Logo image of HBAN

HUNTINGTON BANCSHARES INC (HBAN) Stock Fundamental Analysis

NASDAQ:HBAN - Nasdaq - US4461501045 - Common Stock - Currency: USD

13.67  +0.4 (+3.01%)

After market: 13.75 +0.08 (+0.59%)

Fundamental Rating

3

HBAN gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 398 industry peers in the Banks industry. HBAN has a bad profitability rating. Also its financial health evaluation is rather negative. HBAN has a correct valuation and a medium growth rate. Finally HBAN also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year HBAN was profitable.
In the past year HBAN had a positive cash flow from operations.
Each year in the past 5 years HBAN has been profitable.
HBAN had a positive operating cash flow in each of the past 5 years.
HBAN Yearly Net Income VS EBIT VS OCF VS FCFHBAN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

1.2 Ratios

HBAN has a Return On Assets (0.88%) which is comparable to the rest of the industry.
Looking at the Return On Equity, with a value of 9.12%, HBAN is in line with its industry, outperforming 58.54% of the companies in the same industry.
Industry RankSector Rank
ROA 0.88%
ROE 9.12%
ROIC N/A
ROA(3y)1%
ROA(5y)0.85%
ROE(3y)10.17%
ROE(5y)8.4%
ROIC(3y)N/A
ROIC(5y)N/A
HBAN Yearly ROA, ROE, ROICHBAN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

1.3 Margins

HBAN has a Profit Margin (24.37%) which is comparable to the rest of the industry.
HBAN's Profit Margin has declined in the last couple of years.
HBAN does not have Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) 24.37%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y8.21%
PM growth 5Y-3.17%
GM growth 3YN/A
GM growth 5YN/A
HBAN Yearly Profit, Operating, Gross MarginsHBAN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20 25

0

2. Health

2.1 Basic Checks

HBAN does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for HBAN has been increased compared to 1 year ago.
HBAN has more shares outstanding than it did 5 years ago.
HBAN has a worse debt/assets ratio than last year.
HBAN Yearly Shares OutstandingHBAN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B
HBAN Yearly Total Debt VS Total AssetsHBAN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50B 100B 150B 200B

2.2 Solvency

HBAN has a debt to FCF ratio of 7.10. This is a slightly negative value and a sign of low solvency as HBAN would need 7.10 years to pay back of all of its debts.
HBAN's Debt to FCF ratio of 7.10 is on the low side compared to the rest of the industry. HBAN is outperformed by 72.36% of its industry peers.
A Debt/Equity ratio of 0.60 indicates that HBAN is somewhat dependend on debt financing.
HBAN's Debt to Equity ratio of 0.60 is on the low side compared to the rest of the industry. HBAN is outperformed by 78.39% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.6
Debt/FCF 7.1
Altman-Z N/A
ROIC/WACCN/A
WACC16.41%
HBAN Yearly LT Debt VS Equity VS FCFHBAN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
HBAN Yearly Current Assets VS Current LiabilitesHBAN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

4

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 1.55% over the past year.
HBAN shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -0.32% yearly.
Looking at the last year, HBAN shows a small growth in Revenue. The Revenue has grown by 0.34% in the last year.
HBAN shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 9.61% yearly.
EPS 1Y (TTM)1.55%
EPS 3Y-1.55%
EPS 5Y-0.32%
EPS Q2Q%21.43%
Revenue 1Y (TTM)0.34%
Revenue growth 3Y7.22%
Revenue growth 5Y9.61%
Sales Q2Q%9.51%

3.2 Future

The Earnings Per Share is expected to grow by 6.00% on average over the next years.
Based on estimates for the next years, HBAN will show a small growth in Revenue. The Revenue will grow by 4.14% on average per year.
EPS Next Y13.88%
EPS Next 2Y13.25%
EPS Next 3Y13.21%
EPS Next 5Y6%
Revenue Next Year6.97%
Revenue Next 2Y6.4%
Revenue Next 3Y5.55%
Revenue Next 5Y4.14%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
HBAN Yearly Revenue VS EstimatesHBAN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2B 4B 6B 8B
HBAN Yearly EPS VS EstimatesHBAN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0.5 1 1.5

6

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 10.44, which indicates a very decent valuation of HBAN.
Based on the Price/Earnings ratio, HBAN is valued a bit cheaper than the industry average as 63.07% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 28.29. HBAN is valued rather cheaply when compared to this.
A Price/Forward Earnings ratio of 8.53 indicates a reasonable valuation of HBAN.
Compared to the rest of the industry, the Price/Forward Earnings ratio of HBAN indicates a somewhat cheap valuation: HBAN is cheaper than 72.86% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 21.08. HBAN is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 10.44
Fwd PE 8.53
HBAN Price Earnings VS Forward Price EarningsHBAN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

The rest of the industry has a similar Price/Free Cash Flow ratio as HBAN.
Industry RankSector Rank
P/FCF 11.94
EV/EBITDA N/A
HBAN Per share dataHBAN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
HBAN's earnings are expected to grow with 13.21% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.75
PEG (5Y)N/A
EPS Next 2Y13.25%
EPS Next 3Y13.21%

8

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 4.67%, HBAN is a good candidate for dividend investing.
HBAN's Dividend Yield is a higher than the industry average which is at 3.78.
Compared to an average S&P500 Dividend Yield of 2.57, HBAN pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.67%

5.2 History

The dividend of HBAN has a limited annual growth rate of 2.11%.
HBAN has paid a dividend for at least 10 years, which is a reliable track record.
HBAN has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)2.11%
Div Incr Years0
Div Non Decr Years15
HBAN Yearly Dividends per shareHBAN Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6

5.3 Sustainability

HBAN pays out 58.08% of its income as dividend. This is a bit on the high side, but may be sustainable.
HBAN's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP58.08%
EPS Next 2Y13.25%
EPS Next 3Y13.21%
HBAN Yearly Income VS Free CF VS DividendHBAN Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B
HBAN Dividend Payout.HBAN Dividend Payout, showing the Payout Ratio.HBAN Dividend Payout.PayoutRetained Earnings

HUNTINGTON BANCSHARES INC

NASDAQ:HBAN (4/17/2025, 8:26:06 PM)

After market: 13.75 +0.08 (+0.59%)

13.67

+0.4 (+3.01%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)04-17 2025-04-17/bmo
Earnings (Next)07-18 2025-07-18/bmo
Inst Owners87.29%
Inst Owner Change0.05%
Ins Owners1.07%
Ins Owner Change4.69%
Market Cap19.97B
Analysts78.52
Price Target18.83 (37.75%)
Short Float %4.1%
Short Ratio2.73
Dividend
Industry RankSector Rank
Dividend Yield 4.67%
Yearly Dividend0.72
Dividend Growth(5Y)2.11%
DP58.08%
Div Incr Years0
Div Non Decr Years15
Ex-Date03-18 2025-03-18 (0.155)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.56%
Min EPS beat(2)6.82%
Max EPS beat(2)8.31%
EPS beat(4)4
Avg EPS beat(4)7.48%
Min EPS beat(4)4.87%
Max EPS beat(4)9.94%
EPS beat(8)8
Avg EPS beat(8)6.91%
EPS beat(12)10
Avg EPS beat(12)4.19%
EPS beat(16)12
Avg EPS beat(16)3.32%
Revenue beat(2)1
Avg Revenue beat(2)0.77%
Min Revenue beat(2)-0.63%
Max Revenue beat(2)2.18%
Revenue beat(4)1
Avg Revenue beat(4)-0.19%
Min Revenue beat(4)-1.63%
Max Revenue beat(4)2.18%
Revenue beat(8)2
Avg Revenue beat(8)-0.66%
Revenue beat(12)4
Avg Revenue beat(12)-0.51%
Revenue beat(16)5
Avg Revenue beat(16)-0.33%
PT rev (1m)-3.49%
PT rev (3m)-1.19%
EPS NQ rev (1m)-1%
EPS NQ rev (3m)5.46%
EPS NY rev (1m)-0.04%
EPS NY rev (3m)3.95%
Revenue NQ rev (1m)-0.16%
Revenue NQ rev (3m)2.23%
Revenue NY rev (1m)-0.34%
Revenue NY rev (3m)1.1%
Valuation
Industry RankSector Rank
PE 10.44
Fwd PE 8.53
P/S 2.7
P/FCF 11.94
P/OCF 11
P/B 1.01
P/tB 1.48
EV/EBITDA N/A
EPS(TTM)1.31
EY9.58%
EPS(NY)1.6
Fwd EY11.73%
FCF(TTM)1.14
FCFY8.37%
OCF(TTM)1.24
OCFY9.09%
SpS5.06
BVpS13.51
TBVpS9.24
PEG (NY)0.75
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.88%
ROE 9.12%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 24.37%
GM N/A
FCFM 22.63%
ROA(3y)1%
ROA(5y)0.85%
ROE(3y)10.17%
ROE(5y)8.4%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y8.21%
PM growth 5Y-3.17%
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0.6
Debt/FCF 7.1
Debt/EBITDA N/A
Cap/Depr 22.99%
Cap/Sales 1.94%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 92.84%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score4
WACC16.41%
ROIC/WACCN/A
Cap/Depr(3y)28.25%
Cap/Depr(5y)36.07%
Cap/Sales(3y)2.26%
Cap/Sales(5y)2.68%
Profit Quality(3y)136.93%
Profit Quality(5y)147.23%
High Growth Momentum
Growth
EPS 1Y (TTM)1.55%
EPS 3Y-1.55%
EPS 5Y-0.32%
EPS Q2Q%21.43%
EPS Next Y13.88%
EPS Next 2Y13.25%
EPS Next 3Y13.21%
EPS Next 5Y6%
Revenue 1Y (TTM)0.34%
Revenue growth 3Y7.22%
Revenue growth 5Y9.61%
Sales Q2Q%9.51%
Revenue Next Year6.97%
Revenue Next 2Y6.4%
Revenue Next 3Y5.55%
Revenue Next 5Y4.14%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year43.5%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-33.57%
FCF growth 3Y-2.7%
FCF growth 5Y2.65%
OCF growth 1Y-31.69%
OCF growth 3Y-4.16%
OCF growth 5Y2.89%